secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHEMBIO DIAGNOSTICS, INC. (—)
CIK:        0001092662
Form:       8-K
Filed at:   2023-04-06T23:59:59+00:00
Accession:  0001140361-23-017055
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Chembio Diagnostics receives Nasdaq delisting notice for bid price non-compliance; plans to request hearing
--------------------------------------------------------------------------------

- Received formal delisting notice from Nasdaq on April 6, 2023, for continued non-compliance with minimum bid price rule.
- Non-compliance first disclosed April 2022; two grace periods expired April 3, 2023 without compliance.
- Intends to timely request a hearing before Nasdaq Hearings Panel to stay delisting pending decision.
- No assurance that Panel will continue listing or that compliance can be achieved within any extension.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1092662/000114036123017055/0001140361-23-017055-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1092662/000114036123017055/brhc10051150_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-017055

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer